Neuren Pharmaceuticals | NEU - Umsatzkosten

Aktienkurs
12.58
Täglich Wechseln
-0.42 -3.23%
Monatlich
-1.33%
Jährlich
31.45%
Q2 Prognose
11.77




Umsatzkosten Veränderung Datum
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Avita Medical AUD 3.3M 166K 2025-12
Clinuvel Pharmaceuticals AUD 2.64M 1.06M 2025-12
Genetic Signatures AUD 6.26M 3.95M 2025-12
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
Medical Developments International AUD 7.09M 4.91M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Organon & Co USD 745M 25M 2025-09
Paradigm Biopharmaceuticals AUD 4.5K 2.62K 2025-12
Starpharma Holdings AUD 417K 459K 2025-12
Telix Pharmaceuticals AUD 221.36M 20.78M 2025-12
Viatris USD 2.56B 167.3M 2025-12
Xeris Pharmaceuticals USD 13.66M 49K 2025-12